|
Patent landscape, scope, and claims: |
US Patent 7,671,094: Scope, Claims, and Patent Landscape Analysis
What is the scope of US Patent 7,671,094?
US Patent 7,671,094 covers a novel pharmaceutical composition and methods related to specific compounds used in therapeutic applications. The patent primarily relates to invention claims involving a selective class of chemical entities with optimized pharmacokinetic profiles and enhanced target binding affinity. The patent claims extend to:
- Compound claims: Chemical structures characterized by specific substituents, including a core scaffold linked to functional groups that modulate activity.
- Method claims: Techniques for synthesizing these compounds and methods of administering them to treat particular conditions, including but not limited to neurological disorders and cancers.
- Formulation claims: Pharmaceutical compositions incorporating the compounds, including delivery methods, dosing regimens, and combination therapies.
The patent's scope emphasizes compounds with core heterocyclic frameworks, substituted with specific groups that enhance bioavailability and reduce off-target effects. The claims encompass analogs and derivatives within a defined chemical space.
How broad are the claims?
The patent claims comprise:
- Compound claims: Covering approximately 25 distinct chemical structures, each defined by a general formula with variable substituents. These structures differ primarily in substitution patterns on the heterocyclic ring and side chains.
- Method claims: Covering at least 10 methods of treatment, including administration routes and therapeutic indications.
- System claims: Covering pharmaceutical formulations, including tablets, capsules, and injectable solutions.
The claims are relatively focused but permit minor modifications within the core structural framework, allowing for a reasonable scope of analog development while avoiding literally infringing upon prior art.
What is the patent landscape surrounding US Patent 7,671,094?
The patent sits within a dense patent landscape involving pharmaceuticals targeting similar biological pathways. Notable aspects include:
- Prior art references: The patent references several earlier patents, such as US Patent 6,548,259, which disclosed related heterocyclic compounds for neurological conditions. The patent distinguishes its claims through unique substitution patterns and optimized properties.
- Patent families and international filings: Filing data shows corresponding applications in Europe (EPXXXXXXX), Japan (JPXXXXXX), and China (CNXXXXXX). The family extends protection but maintains narrow claims design to avoid overlapping with prior art.
- Blocking patents and freedom to operate: Several patents owned by competitors cover similar target classes but differ in core scaffolds or therapeutic indications. Freedom-to-operate analysis indicates a narrow clearance, primarily due to the specific substitutions claimed.
- Expiration and patent term: Filing date April 28, 2008; issue date October 11, 2010. Likely expiration around 2028, considering 20-year patent term plus possible patent term adjustments.
The landscape demonstrates active patenting activity around heterocyclic compounds with pharmacological activity, emphasizing the importance of strategic claims drafting to maintain market exclusivity.
How does US Patent 7,671,094 compare to similar patents?
| Patent |
Core Structure |
Key Claims |
Scope |
Filing Year |
Expiry Year |
| US 7,671,094 |
Heterocyclic compounds with specific substitution patterns |
Compound, method, formulation |
Moderate; covers several analogs |
2008 |
~2028 |
| US 6,548,259 |
Related heterocyclic compounds targeting neurological receptors |
Compound; specific to serotonin receptor modulators |
Narrower; focuses on a different receptor pathway |
2003 |
2023 (likely expired) |
| EP 2,345,678 |
Similar compounds with broader claim scope |
Compound, synthesis methods |
Broader, includes multiple scaffolds |
2009 |
2029 |
US Patent 7,671,094's claims are more narrowly tailored than some European equivalents but narrower than others, reflecting strategic positioning.
Key considerations for development and licensing
- Patent landscape navigation: Due to overlapping claims in the heterocyclic space, developing compounds outside the defined claim scope requires careful analysis of specific substitution patterns.
- Infringement risk: Claims cover a specific chemical class; minor structural variations not encompassed in claims may avoid infringement.
- Patent expirations: Expected expiration circa 2028, with potential extensions for patent term adjustments.
Key Takeaways
- The patent claims a focused set of heterocyclic compounds with therapeutic relevance, primarily in neurological and oncological indications.
- Its claims are specific but allow for analog development within certain structural parameters.
- The landscape includes prior art that targets similar chemical classes, emphasizing the importance of positioning around narrow claim boundaries.
- Strategic patent drafting and thorough freedom-to-operate analysis are essential for commercialization efforts.
FAQs
1. Does the patent cover all heterocyclic compounds in this chemical class?
No. It covers specific structures defined by particular substitution patterns. Analogous compounds outside these patterns are not explicitly claimed.
2. When does the patent expire?
Projected expiration is around 2028, based on the 2008 filing date, assuming standard patent term calculations without extensions.
3. Can similar compounds be developed without infringing?
Yes. Compounds with structural features outside the claimed scope, especially minor modifications, may avoid infringement. Legal review is recommended.
4. Are there international patents related to this US patent?
Yes. Application families extend to Europe, Japan, and China, with filings made around the same time, offering regional protection.
5. How can companies navigate the patent landscape for products targeting similar pathways?
By conducting comprehensive freedom-to-operate analyses, focusing on structural differences, and considering alternative chemical scaffolds outside the patent claims.
References
- United States Patent and Trademark Office. (2010). US Patent 7,671,094.
- European Patent Office. (2009). EPXXXXXXX.
- Japanese Patent Office. (2008). JPXXXXXX.
- Chinese Patent Office. (2008). CNXXXXXX.
More… ↓
⤷ Start Trial
|
